| (Values in U.S. Thousands) | Dec, 2016 | Dec, 2015 | Dec, 2014 | Dec, 2013 | Dec, 2012 |
| Sales | 0 | 0 | 9,320 | 2,490 | 0 |
| Sales Growth | unch | -100.00% | +274.30% | unch | unch |
| Net Income | -23,550 | -63,900 | -36,610 | -76,680 | -34,970 |
| Net Income Growth | +63.15% | -74.54% | +52.26% | -119.27% | -204.62% |
Galena Biopharma In (GALE)
0.26 -0.02 (-7.14%) 12/29/17 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Fri, Dec 29th, 2017
Galena Biopharma, Inc. is a biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. Galena Biopharma, Inc., formally known as RXi Pharmaceuticals Corporation, is based in Portland, Oregon.